New Case Study 📣 Learn how we used our business development process to successfully secure a licensing partnership for an oncology asset (while retaining U.S. rights) within 6 months. #licensing #pharma #biopharma #partnering #strategicpartner #druglicensing #pharmalicensing Get the case study: https://buff.ly/3JUupfI
Sosna + Co’s Post
More Relevant Posts
-
Discover how Ikena Oncology transformed their #contracting process with #CLM. Learn from Angelina Bellanton, who has a decade of experience in IP and #contracts in the #pharmaceutical industry and is a two-time #CLM implementation champion. Watch our #ondemand webinar now: https://hubs.ly/Q02g7Ktj0
-
-
Last week, Argenica Therapeutics lodged our Appendix 4C Quarterly Cashflow Report for the 12-month period ended 30 June 2024. One key highlight from the report was the progress made in our Phase 2 Clinical Trial. Here is an overview of the highlight Access the full report here ➡️ https://bit.ly/4ftygiq #ASX #AGN #investorupdate #stroke #clinicaltrial
-
-
As more clinical trials in #Psychedelics emerge, it’s important to design studies with the patient’s condition in mind. Make sure to check out my team member’s presentation at the Psychedelic Therapeutics & Drug Development Conference to learn more! https://bit.ly/4bnRvXY
-
Senior Operations Associate, Clinical Assessment Technologies at Worldwide Clinical Trials
As more clinical trials in #Psychedelics emerge, it’s important to design studies with the patient’s condition in mind. Make sure to check out my team member’s presentation at the Psychedelic Therapeutics & Drug Development Conference to learn more! https://bit.ly/4bnRvXY
Presentation | Psychedelic Therapeutics & Drug Development Conference
-
Senior Human Resources Leader │ Servant Leader │ Total Rewards │ Benefits │ Compensation │ Engagement │ HRIS │ HR Operations │ International Mobility │ Diversity & Inclusion │ National │ Regional │ Global
As more clinical trials in #Psychedelics emerge, it’s important to design studies with the patient’s condition in mind. Make sure to check out my team member’s presentation at the Psychedelic Therapeutics & Drug Development Conference to learn more! https://bit.ly/4bnRvXY
Presentation | Psychedelic Therapeutics & Drug Development Conference
-
As more clinical trials in #Psychedelics emerge, it’s important to design studies with the patient’s condition in mind. Make sure to check out my team member’s presentation at the Psychedelic Therapeutics & Drug Development Conference to learn more! https://bit.ly/4bnRvXY
Presentation | Psychedelic Therapeutics & Drug Development Conference
-
Check out Aleon’s Regulatory Insights article: FDA Accelerated Approval Strategy for Oncology Drug Development (https://bit.ly/3MSfYdn) where our team outlines the current key considerations from FDA pertaining to accelerated approval, expectations for the oncology pivotal trial supporting accelerated approval, recent accelerated approvals, and confirmatory trials following accelerated approval. Aleon’s team stands ready to evaluate your development goals and create a confident roadmap for success. Contact us for a complimentary consultation at bd@aleonpharma.com. #regulatoryaffairs #RAPS #TOPRA #FDA #acceleratedapproval
-
-
By engaging in voluntary licensing, #pharma companies can improve availability and affordability of innovative #CancerMeds in low- and middle-income countries #LMICs. The 2022 #AccesstoMedicine Index found that Novartis signed the first non-exclusive voluntary licensing agreement for a #cancer drug with Medicines Patent Pool, the first such agreement for a non-communicable disease. We must keep this momentum on access to new therapies, with more non-voluntary licence agreements, especially for #NCDs. Read the key finding here ➡️ https://lnkd.in/eUqZ3xxG #WorldCancerDay #ClosetheCareGap #CancerCare #AccesstoMedicine #EquitableAccess #AccesstoHealthcare #GlobalHealth
-
-
Solution Oriented Critical Thinker / Working at the crossroad of clinic, operations, and business
As more clinical trials in #Psychedelics emerge, it’s important to design studies with the patient’s condition in mind. Make sure to check out my team member’s presentation at the Psychedelic Therapeutics & Drug Development Conference to learn more! https://bit.ly/4bnRvXY
Presentation | Psychedelic Therapeutics & Drug Development Conference
-
As more clinical trials in #Psychedelics emerge, it’s important to design studies with the patient’s condition in mind. Make sure to check out my team member’s presentation at the Psychedelic Therapeutics & Drug Development Conference to learn more! https://bit.ly/4bnRvXY
Presentation | Psychedelic Therapeutics & Drug Development Conference
